Hospira: Regulatory Woes, Pipeline, And Potential Takeout Offer Asymmetric...
By Buddy Lyons, CFA: Hospira (HSP) is a provider of specialty injectable pharmaceuticals and infusion technologies. Despite its regulatory troubles of the past five years, Hospira is strategically one...
View ArticleGreat Investors’ Best Ideas Conference Notes 2013: Price, Akre, Gabelli,...
Below are some brief notes from the 7th annual Great Investors' Best Ideas Conference in Dallas benefiting the Michael J. Fox Foundation for Parkinson's Research and the Vickery Meadow Youth...
View ArticleWall Street Breakfast: Tax Inversions, Solar Tariffs, Samsung Delay
Wall Street Breakfast Editors submit: Outstanding Performance Article Rewards Today, we're excited to announce our first two Outstanding Performance award winners. Each author receives $2,500. Read...
View ArticleWall Street Breakfast: Condensate Leaves U.S. Shores As Industry Demands...
Wall Street Breakfast Editors submit: EconomyA tanker loaded with $40M of ultralight ...
View Article
More Pages to Explore .....